OPTIMIZATION OF FORMULATION PARAMETERS OF SIMVASTATIN LOADED PLGA NANOPARTICLES BY USING 33 FACTORIAL DESIGN
Abstract
Factorial design enables researchers to study and understand how multiple factors affect a dependent variable, both independently and jointly. In present report, 33 factorial design was used to study the combined influence of three independent variables in preparation of Simvastatin loaded Poly (D, L Lactide -co- Glycolide) (PLGA) nanoparticles. Nanoparticles were prepared by nanoprecipitation method. The process variables like rate of addition of organic phase to aqueous phase, temperature, speed of magnetic stirrer and time to evaporate organic phase were kept constant throughout the investigation. The formulation variables like concentration of stabilizer (Polyvinyl alcohol), drug (Simvastatin): polymer ratio (PLGA), and organic (acetone): aqueous phase ratio were selected as independent variables. Prepared nanoparticles were evaluated for particle size (PS) and entrapment efficiency (EE). PS and EE were selected as dependent variables. The coded values of independent variables were subjected to multiple regressions to derive a second order polynomial equation (full model). After neglecting the non-significant terms from full model, F-Statistics was applied to set up reduce polynomial equation. Among the three independent variables, value of coefficient of drug: polymer ratio was found to be maximum. This revealed that major contributing variable for PS and EE in nanoparticles is drug: polymer ratio. Two dimensional contour plots and three dimensional response surface plots were established by varying levels of two factors and keeping the third factor at fixed level at a time. Thus the derived equation, surface response plot and contour plot helps in predicting the value of independent variables for optimum PS and EE in preparation of Simvastatin loaded PLGA nanoparticles.
Keywords:
Factorial design, Simvastatin, PLGA nanoparticles, contour plots, surface response plotDOI
https://doi.org/10.25004/IJPSDR.2016.080404References
2. Francis MF, Cristea M, Winnik FM. Polymeric micelles for oral drug delivery: Why and how. Pure Appl Chem. 2004; 76: 1321-1335.
3. Gilding DK, Reed AM. Biodegradable polymers for use in surgery- poly (glycolic)/poly (lactic acid) homo and copolymers. Polymer. 1979; 20: 1459-1464.
4. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv Rev. 1997; 28: 5-24.
5. ZOOCOR tablet leaflet, Published by Merck & CO., NJ USA.
6. Simvastatin - www.drugs.com/pro/simvastatin.html.
7. 19th WHO model list of essential medicines, WHO, April 2015.
8. Schachter M. Chemical, pharmacokinetic and pharmacodynamics properties of statins: an update. Fundam Clin Pharmacol. 2005; 19(1): 117–125.
9. Cochran WG, Cox GM. Experimental Designs. 2nd edition. New York: Wiley, 1957.
10. Seth AK, Misra A. Mathematical modelling of preparation of acyclovir liposomes: reverse phase evaporation method. J Pharm Pharm Sci. 2002; 5: 285–291.
11. Lalani J, Rathi M, Lalan M, Misra A. Protein functionized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamics studies. Drug Dev Ind Pharma. 2013; 39(6): 854-864.
12. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm.1989; 55: R1–R4.
13. Armstrong NA, James KC. Pharmaceutical experimental design and interpretation, Tailor and Francis Publishers USA, 1996.
14. Box G, Hunter W, Hunter J. An introduction to design, data analysis and model building. In: Statistics for Experimenters, Wiley New York, 1978, pp. 510-520.
15. Giry K, Viana M, Genty M, Wüthrich P, Chulia D. Surface responses and desirability functions to determine optimal granulation domains. Drug Dev Ind Pharm. 2010; 36:1016–1026.
16. Gohel MC, Patel LD. Processing of Nimusulide-PEG 400-PG-PVP solid dispersion: Preparation, characterization, and in vitro dissolution. Drug Dev Ind Pharma. 2003; 29(3): 299-310.
17. Adinarayana K, Ellaiah P. Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J Pharm Pharmaceut Sci. 2002; 5(3): 281-287.
Published

